AC-OLE-01-VA Tolerability Study in Healthy Participants Under Different Dosing Conditions
Status:
Not yet recruiting
Trial end date:
2023-02-01
Target enrollment:
Participant gender:
Summary
This is an open-label, 3-arm study to compare tolerability of three different titration and
dosing schedules of the AC-OLE-01-VA formulation of tricaprilin.
Following a screening of up to 28 days, eligible participants will be initially randomised to
one of 2 arms (Arm 1 or Arm 2). Arms 1 and 2 will be completed in advance of Arm 3 with all
subsequent participants allocated to Arm 3.